# Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center

> **NCT06739382** · PHASE3 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 64 (actual)

## Conditions studied

- Ventilation Acquired Pneumonia

## Interventions

- **COMBINATION_PRODUCT:** extended meropenem infusion in combination with other options such as Polymyxin, Tigecycline, Ertapenem, or Amikacin.
- **COMBINATION_PRODUCT:** two β-lactam antibiotics plus a single non-β-lactam antibiotic
- **OTHER:** Control group received standard therapy

## Key facts

- **NCT ID:** NCT06739382
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06739382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06739382, "Management of Ventilation Acquired Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06739382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*